These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Topiramate: a broad spectrum antiepileptic administered to 224 patients with refractory epilepsies]. Herranz JL Rev Neurol; 2000 Nov 1-15; 31(9):822-8. PubMed ID: 11127082 [TBL] [Abstract][Full Text] [Related]
3. Topiramate as a new antiepileptic drug in epileptic children in Iran. Fallah R Indian J Pediatr; 2006 Dec; 73(12):1073-5. PubMed ID: 17202632 [TBL] [Abstract][Full Text] [Related]
4. [Topiramate, a new antiepileptic drug]. Herranz JL Rev Neurol; 1997 Aug; 25(144):1221-5. PubMed ID: 9340155 [TBL] [Abstract][Full Text] [Related]
5. Topiramate and metabolic acidosis in infants and toddlers. Philippi H; Boor R; Reitter B Epilepsia; 2002 Jul; 43(7):744-7. PubMed ID: 12102678 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes. Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380 [TBL] [Abstract][Full Text] [Related]
7. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting. Helmstaedter C; Witt JA Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473 [TBL] [Abstract][Full Text] [Related]
8. [Long-term efficacy and tolerance of topiramate in 44 children with resistant epilepsy]. Herranz JL; Arteaga R Rev Neurol; 1999 Jun 1-15; 28(11):1052-6. PubMed ID: 10390772 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics and indications of topiramate]. Nieto-Barrera M Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660 [TBL] [Abstract][Full Text] [Related]
11. Topiramate and metabolic acidosis. Wilner A; Raymond K; Pollard R Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131 [TBL] [Abstract][Full Text] [Related]
13. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
14. Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Grabenstatter HL; Ferraro DJ; Williams PA; Chapman PL; Dudek FE Epilepsia; 2005 Jan; 46(1):8-14. PubMed ID: 15660763 [TBL] [Abstract][Full Text] [Related]
15. Review of topiramate for the treatment of epilepsy in elderly patients. Sommer BR; Fenn HH Clin Interv Aging; 2010 Apr; 5():89-99. PubMed ID: 20458347 [TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. Shank RP; Maryanoff BE CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025 [TBL] [Abstract][Full Text] [Related]
17. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy. Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981 [TBL] [Abstract][Full Text] [Related]
18. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389 [TBL] [Abstract][Full Text] [Related]
19. Practical aspects of the use of topiramate in patients with epilepsy. Sander JW Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962 [TBL] [Abstract][Full Text] [Related]